MedTrace Logo

Neuro 1 vs. Neuro 2 Sound Processors

NCT03756337 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-10-20

No results posted yet for this study

Summary

This study evaluates the benefit of Neuro 1 sound processor upgrade in speech perfomance in adults. Half of participants will be tested with Neuro 1 first and Neuro 2, while the other half will be tested with Neuro 2 first and then Neuro 1.

Conditions

  • Hearing Loss, Sensorineural
  • Cochlear Hearing Loss

Interventions

DEVICE

Neuro 1 & Neuro 2

participant common fitting map used for tests

DEVICE

Neuro 2 & Neuro 1

participant common fitting map used for tests

Sponsors & Collaborators

  • Oticon Medical

    lead INDUSTRY

Principal Investigators

  • David Peter Morris, MD · Dalhousie University, Halifax,NS, Canada

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2020-01-10
Completion
2020-01-10

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03756337 on ClinicalTrials.gov